BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1325073)

  • 1. [Prevalence of antibodies against CMV in Grenada].
    Rojo MD; García MV; Oyonarte S; Mendoza J; Carazo C; Fernández-Montoya A
    Sangre (Barc); 1992 Aug; 37(4):293-5. PubMed ID: 1325073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
    Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
    Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
    Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
    Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
    Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood donor selection in providing anticytomegalovirus-negative blood components].
    Koerner K; Freudenberg J; Kubanek B
    Dtsch Med Wochenschr; 1989 Feb; 114(6):203-7. PubMed ID: 2537170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral screening of organ donors and human cytomegalovirus seroprevalence in the Hungarian population].
    Varga M; Görög D; Kári D; Fazekas J; Sárváry E; Sulyok B; Perner F
    Orv Hetil; 2001 Nov; 142(47):2631-3. PubMed ID: 11778361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of cytomegalovirus in blood donation].
    Albert S; Kühnl P; Sibrowski W; Seidl S; Doerr HW
    Infusionstherapie; 1990 Feb; 17(1):48-56. PubMed ID: 2159951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomegalovirus seroepidemiology in the community of Madrid].
    de Ory Manchón F; Sanz Moreno JC; Castañeda López R; Ramírez Fernández R; León Rega P; Pachón del Amo I
    Rev Esp Salud Publica; 2001; 75(1):55-62. PubMed ID: 11400415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological survey of antibodies to cytomegalovirus in the Santa Cruz region of Bolivia.
    Bartoloni A; Aquilini D; Roselli M; Parri F; De Majo E; Nunez LE; Corti G; Paradisi F
    J Trop Med Hyg; 1989 Dec; 92(6):391-2. PubMed ID: 2558225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV antibody prevalence and seroincidence in plateletpheresis donors.
    Boeke CE; Pauly ME; Hatch-Stock H; Jackson JB
    J Clin Apher; 2008; 23(2):63-5. PubMed ID: 18181166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of cytomegalovirus infection in a selected population in Jamaica.
    Prabhakar P; Bailey A; Smikle MF; Ashley D
    West Indian Med J; 1992 Dec; 41(4):133-5. PubMed ID: 1337805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the incidence of complement-fixing antibodies against the cytomegalovirus in 339 subjects].
    Georges JC; Rio Y; de Lavergne E
    Sem Hop; 1975 Apr; 51(18):1213-8. PubMed ID: 175471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.
    Furui Y; Satake M; Hoshi Y; Uchida S; Suzuki K; Tadokoro K
    Transfusion; 2013 Oct; 53(10):2190-7. PubMed ID: 23968359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cytomegalovirus seropositivity in an urban childhood population in Cameroon.
    Stroffolini T; Ngatchu T; Chiaramonte M; Giammanco A; Maggio M; Sarzana A; Taormina S
    New Microbiol; 1993 Jan; 16(1):83-5. PubMed ID: 8385733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
    Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
    Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seroprevalence of cytomegalovirus and Toxoplasma gondii in healthy subjects under 30 years old in Santiago, Chile].
    Abarca K; Vial PA; Zamorano J; Paris C; Ferrés M; Villarroel L; Ferreccio C
    Rev Med Chil; 1997 May; 125(5):531-8. PubMed ID: 9497573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cytomegalovirus in Thai blood donors by monoclonal staining of blood leukocytes.
    Amarapal P; Tantivanich S; Balachandra K
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):148-53. PubMed ID: 11485078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
    Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
    J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroepidemiologic study of cytomegalovirus in childbearing age women in the community of Madrid].
    de Ory F; Castañeda R; Ramírez R; Pachón I
    Med Clin (Barc); 1998 Sep; 111(8):290-1. PubMed ID: 9810546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.